DiaSorin SpA
MIL:DIA

Watchlist Manager
DiaSorin SpA Logo
DiaSorin SpA
MIL:DIA
Watchlist
Price: 71.78 EUR -0.61%
Market Cap: 4B EUR

DiaSorin SpA
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

DiaSorin SpA
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
DiaSorin SpA
MIL:DIA
EPS (Diluted)
€4
CAGR 3-Years
-8%
CAGR 5-Years
5%
CAGR 10-Years
N/A
El En SpA
MIL:ELN
EPS (Diluted)
€0
CAGR 3-Years
4%
CAGR 5-Years
15%
CAGR 10-Years
N/A
No Stocks Found

DiaSorin SpA
Glance View

In the heart of the global healthcare landscape, DiaSorin SpA stands as a testament to innovation and precision in the field of biotechnology. Founded in 1968 in Italy, the company built its reputation on developing and producing diagnostic tests that help identify and monitor diseases. With a primary focus on immunodiagnostic and molecular diagnostic products, DiaSorin excels in creating high-quality, reliable solutions that clinicians and labs around the world depend on. Their product portfolio ranges widely, covering infectious diseases, oncology, endocrinology, and more. By leveraging cutting-edge research and development processes, DiaSorin not only prioritizes accuracy and efficiency in its testing solutions but also adapts to the ever-evolving demands of the medical world, cementing its role as a leader in diagnostic innovation. From a business perspective, DiaSorin's revenue streams are deeply intertwined with its prowess in developing proprietary testing technologies, including both instruments and consumables. The company operates with a dual-channel business model where it sells diagnostic machines to laboratories, hospitals, and clinics while simultaneously providing the reagents and kits necessary for these machines' continuous operation. This approach ensures not only a sale of sophisticated equipment but also a recurring revenue stream from the consumables needed for diagnostics. With a strategic emphasis on research and partnerships, DiaSorin has expanded its reach globally, ensuring its products meet diverse regional healthcare requirements. Through a combination of robust product offerings and strategic global expansion, DiaSorin continues to thrive and maintain its position as a pivotal contributor to the field of diagnostic medicine.

DIA Intrinsic Value
104.43 EUR
Undervaluation 31%
Intrinsic Value
Price

See Also

What is DiaSorin SpA's EPS (Diluted)?
EPS (Diluted)
4.2 EUR

Based on the financial report for Jun 30, 2025, DiaSorin SpA's EPS (Diluted) amounts to 4.2 EUR.

What is DiaSorin SpA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
5%

Over the last year, the EPS (Diluted) growth was 41%. The average annual EPS (Diluted) growth rates for DiaSorin SpA have been -8% over the past three years , 5% over the past five years .

Back to Top